B-type natriuretic peptide

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

SUSTAINED-RELEASE DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A CNP COMPOUND, AN NPR-B COMPOUND, A TIE-2 AGONIST, OR NEUROTROPHIC AGENT FOR USE FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
EP 3810082 A1Applicant: CELLA THERAPEUTICS LLCPriority: 2018
CN
EP
US
WO
13 publications
AGENT FOR THE TREATMENT OF ALOPECIA
EP 3269382 A1Applicant: IGISU CO LTDPriority: 2011
CN
EP
US
8 publications
COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN
US 2012208756 A1Applicant: ENDO KYOKOPriority: 2009
US
5 publications
THERAPEUTIC AGENT FOR RHINITIS
US 2013045921 A1Applicant: IGISU COMPANY LTDPriority: 2009
US
5 publications
MODIFIED B-TYPE NATRIURETIC PEPTIDE
- EP 4337668 A1
  Applicant: ANTLIA BIOSCIENCE INCPriority: 2021
  CN
  EP
  US
  WO
  4 publications
- WO 2025106567 A1
  Applicant: ANTLIA BIOSCIENCE INCPriority: 2023
  WO
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US 7632647 B2Applicant: BIOSITE INCPriority: 2001
US
4 publications
ANTIBODIES BINDING SPECIFICALLY TO NT-PROBNP AND USE THEREOF
EP 4169946 B1Applicant: BIONOTE INCPriority: 2021
EP
US
3 publications
COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
US 2008045444 A1Applicant: BIOSITE INCPriority: 2006
US
3 publications
BONE REPAIR PROMOTER
US 2015125457 A1Applicant: DAIICHI SANKYO CO LTDPriority: 2012
CN
US
2 publications
MUTANT GNP AND USE THEREOF
WO 2026145618 A1Applicant: TIBET RHODIOLA PHARMACEUTICAL HOLDING COPriority: 2024
CN
WO
2 publications

Drugs

B-type natriuretic peptide

Patents

MODIFIED B-TYPE NATRIURETIC PEPTIDE